After European tests found the key ingredient increased the risk of serious heart problems, Abbott Laboratories on Oct. 8 said it was pulling its obesity drug Meridia from the US market.
128211
Abbott pulls obesity drug from US market
4747
Chokeberry extract regulates weight gain
116651
Obesity and alcohol act together to increase the risk of liver disease
8379
Abbott to remove live betting ads
144052
Public Citizen calls for ban of popular weight loss drug, Meridia
93120
Archer Daniels Midland to end venture with Metabolix
117029
The Japanese pharmaceutical market has become increasingly difficult
30087
BPA found in cans and plastic containers linked to cardiovascular disease
39611
Calcium supplements pose threat to heart attacks
43769
Abbott Labs swings to profit;
62644
Dietary supplements illegally labeled:
9382
Obesity, smoking may raise blood clot risk
4702
GPC Biotech Reports that Marketing Authorization Application for satraplatin is to be Withdrawn
34268
Outbreak in Europe blamed on 'super-toxic' strain
4268
Study has shown to reverse obesity
11901
Blood thinner being recalled
93099
Non-alcoholic fatty liver disease may lower cardiovascular fitness